420099 Sigma-AldrichJAK Inhibitor I - CAS 457081-03-7 - Calbiochem
JAK Inhibitor I, CAS 457081-03-7, is a potent, reversible, cell-permeable, and ATP-competitive inhibitor of JAK 1 (IC₅₀ = 15 nM), JAK2 (IC₅₀ = 1 nM), JAK3 (Ki = 5 nM) and Tyk2 (IC₅₀ = 1 nM).
More>> JAK Inhibitor I, CAS 457081-03-7, is a potent, reversible, cell-permeable, and ATP-competitive inhibitor of JAK 1 (IC₅₀ = 15 nM), JAK2 (IC₅₀ = 1 nM), JAK3 (Ki = 5 nM) and Tyk2 (IC₅₀ = 1 nM). Less<<Synonyms: 2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one, Pyridone 6, P6, DBI, JAK1 Inhibitor I, JAK2 Inhibitor I, JAK3 Inhibitor X
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
457081-03-7 | C₁₈H₁₆FN₃O |
Pricing & Availability
Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
---|---|---|---|---|---|---|
420099-1MG |
|
Plastic ampoule | 1 mg |
|
— | |
420099-500UG |
|
Plastic ampoule | 500 μg |
|
— |
Description | |
---|---|
Overview | A potent, reversible, cell-permeable, and ATP-competitive inhibitor of Janus protein tyrosine kinases (JAKs). Displays potent inhibitory activity against JAK1 (IC50 = 15 nM for murine JAK1), JAK2 (IC50 = 1 nM), JAK3 (Ki = 5 nM), and Tyk2 (IC50 = 1 nM). Inhibits other kinases at much higher concentrations. Shown to inhibit IL2- and IL4-dependent proliferation of CTLL cells and block the phosphorylation of STAT5; and further induce growth inhibition of multiple myeloma cells expressing activated JAKs and STAT3, unlike AG 490 (Cat. No. 658401). A 10 mM (500 µg/162 µl) solution of JAK Inhibitor I (Cat. No. 420097) in DMSO is also available. |
Catalogue Number | 420099 |
Brand Family | Calbiochem® |
Synonyms | 2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one, Pyridone 6, P6, DBI, JAK1 Inhibitor I, JAK2 Inhibitor I, JAK3 Inhibitor X |
References | |
---|---|
References | Pedranzini, L., et al. 2006. Cancer Res. 66, 9714. Lucet, I.S., et al. 2005. Blood 107, 176. Thompson, J.E., et al. 2002. Bioorg. Med. Chem. Lett. 12, 1219. |
Product Information | |
---|---|
CAS number | 457081-03-7 |
ATP Competitive | Y |
Form | Off-white solid |
Hill Formula | C₁₈H₁₆FN₃O |
Chemical formula | C₁₈H₁₆FN₃O |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
420099-1MG | 04055977187878 |
420099-500UG | 04055977187885 |
Documentation
JAK Inhibitor I - CAS 457081-03-7 - Calbiochem MSDS
Title |
---|
JAK Inhibitor I - CAS 457081-03-7 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
420099 |
References
Reference overview |
---|
Pedranzini, L., et al. 2006. Cancer Res. 66, 9714. Lucet, I.S., et al. 2005. Blood 107, 176. Thompson, J.E., et al. 2002. Bioorg. Med. Chem. Lett. 12, 1219. |
Brochure
Title |
---|
An Introduction to Inhibitors and Their Biological Applications - 1st Edition |
Pathways and Biomarkers of JAK/STAT Signaling |
Technical Info
Title |
---|
JAK/STAT Signaling Research Focus |
Data Sheet
Title |
---|
Reprogramming Cell Fate and Function Novel Strategies for iPSC Generation, Characterization, and Differentiation |
Citations
Title | |
---|---|
|